DNA Repair

Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts

Volumn 2, Issue , 2008, Pages 822-846

  Schrauder, Michael ^a   Wiesmüller, Lisa ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Homologous; Immunodeficiency; Oligonucleotide; Oxidation; Somatic hypermutation

Indexed keywords

EID: 84891305522     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619665.ch32     Document Type: Chapter

References (87)

1. Wood, R. D., M. Mitchell, J. Sgouros and T. Lindahl. 2001. Human DNA repair genes. Science 291:1284-1288.
2. Hoeijmakers, J. H. J. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366-373.
3. Schärer, O. D. 2003. Chemistry and biology of DNA repair. Angew Chem Int Ed Engl 42:2946-2974.
4. Peterson, C. L. and J. Cote. 2004. Cellular machineries for chromosomal DNA repair. Genes Dev 18:602-616.
5. Sancar, A., L. A. Lindsey-Boltz, K. UnsalKacmaz and S. Linn. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39-85.
6. Barnes, D. E. and T. Lindahl. 2004. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet 38:445-476.
7. Ide, H. and M. Kotera. 2004. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull 27:480-485.
8. Li, Z., C. J. Woo, M. D. Iglesias-Ussel, D. Ronai and M. D. Scharff. 2004. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev 18:1-11.
9. Masson, M., C. Niedergang, V. Schreiber, S. Müller, J. Menissier-de Murcia and G. de Murcia. 1998. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18:3563-3571.
10. Dantzer, F., G. de La Rubia, J. MenissierDe Murcia, Z. Hostomsky, G. de Murcia and V. Schreiber. 2000. Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1. Biochemistry 39:7559-7569.
11. Allinson, S. L., I. I. Dianova and G. L. Dianov. 2003. Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing. Acta Biochim Pol 50:169-179.
12. Offer, H., R. Wolkowicz, D. Matas, S. Blumenstein, Z. Livneh and V. Rotter. 1999. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett 450:197-204.
13. Zhou, J., J. Ahn, S. H. Wilson and C. Prives. 2001. A role for p53 in base excision repair. EMBO J 20:914-923.
14. Gerson, S. L. 2004. MGMT: its role in cancer aetiology and cancer therapeutics. Nature 4:296-307.
15. Cleaver, J. E. and E. Crowley. 2002. UV damage, DNA repair and skin carcinogenesis. Front Biosci 7:d1024-1043.
16. Costa, R. M. A., V. Chigancas, R. da Silva Galhardo, H. Carvalho and C. F. M. Menck. 2003. The eukaryotic nucleotide excision repair pathway. Biochimie 85:1083-1099.
17. Hanawalt, P. C. 2000. The bases for Cockayne syndrome. Nature 405:415-416.
18. Friedberg, E. C. 2004. The role of endogenous and exogenous DNA damage and mutagenesis. Curr Opin Genet Dev 14:5-10.
19. Evans, E. and E. Alani. 2000. Roles for mismatch repair factors in regulating genetic recombination. Mol Cell Biol 20:7839-7844.
20. Marti, T. M., C. Kunz and O. Fleck. 2002. DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 191:28-41.
21. Stojic, L., R. Brun and J. Jiricny. 2004. Mismatch repair and DNA damage signalling. DNA Repair 3:1091-1101.
22. Jiricny, J. and M. Nyström-Lahti. 2000. Mismatch repair defects in cancer. Curr Opin Genet Dev 10:157-161.
23. Kolodner, R. D. and G. T. Marsischky. 1999. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 9:89-96.
24. Peltomäki, P. 2001. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. HumMol Genet 10:735-740.
25. Marti, T. M., C. Kunz and O. Fleck. 2002. The major pathway for correction of mismatches arising during replication is the MMR pathway. J Cell Physiol 191:28-41.
26. Wu, X., Z. Khalpey and M. Cascalho. 2004. Cellular physiology of mismatch repair. Curr Pharm Des 10:4121-4126.
27. Acharya, S., P. L. Foster, P. Brooks and R. Fishel. 2003. The coordinated function of the E. coli MutS and MutL proteins in mismatch repair. Mol Cell 12:233-246.
28. Jackson, S. P. 2002. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687-696.
29. Valerie, K. and L. F. Povirk. 2003. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22:5792-5812.
30. Ferguson D. O. and F. W Alt FW. 2001. DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene 20:5572-5579.
31. Petrini, J. H. J. and T H. Stracker. 2003. The cellular response to DNA doublestrand breaks: defining the sensors and mediators. Trends Cell Biol 13:458-462.
32. Assenmacher, N. and K. P. Hopfner. 2004. MRE11/RAD50/NBS1: complex activities. Chromosoma 113:157-166.
33. Krejci, L., L. Chen, S. Van Komen, P. Sung and A. Tomkinson. 2003. Mending the break: two DNA double-strand break repair machines in eukaryotes. Nucleic Acids Res Mol Biol 74:159-201.
34. Constantinou, A., X. B. Chen, C. H. McGowan and S. C. West. 2002. Holliday junction resolution in human cells: two junction endonucleases with distinct substrate specificities. EMBO J 21:5577-5585.
35. Masson, J. Y., M. C. Tarsounas, A. Z. Stasiak, A. Stasiak, R. Shah, M. J. Mcllwraith, F. E. Benson and S. C. West. 2001. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev 15:3296-3307.
36. Liu, Y., J. Y. Masson, R. Shah, P. O'Regan and S. C. West. 2004. RAD51C is required for Holliday junction processing in mammalian cells. Science 303:243-246.
37. Dronkert, M. L. G. and R. Kanaar. 2001. Repair of DNA interstrand cross-links. Mutat Res 486:217-247.
38. Stark, J. M., A. J. Pierce, J. Oh, A. Pastink and M. Jasin. 2004. Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol Cell Biol 24:9305-9316.
39. Lees-Miller, S. P. and K. Meek. 2003. Repair of DNA double strand breaks by non-homologous end joining. Biochimie 85:1161-1173.
40. Lieber, M., Y. Ma, U. Pannicke and K. Schwarz. 2003. Mechanism and regulation of human non-homologous DNA end-joining. Nature 4:712-720.
41. Saintigny, Y., F. Delacote, G. Vares, F. Petitot, S. Lambert, D. Averbeck and B. S. Lopez. 2001. Characterization of homologous recombination induced by replication inhibition in mammalian cells. EMBO J 20:3861-3870.
42. Rothstein, R., B. Michel and S. Gangloff. 2000. Replication fork pausing and recombination or "gimme a break". Genes Dev 14:1-10.
43. Rothkamm, K., I. Krüger, L. H. Thompson and M. Löbrich. 2003. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23:5706-5715.
44. Guirouilh-Barbat, J., S. Huck, P. Bertrand, L. Pirzio, C. Desmaze, L. Sabatier and B. S. Lopez. 2004. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol Cell 14:611-623.
45. Yoshida, K. and Y. Miki. 2004. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription and cell cycle in response to DNA damage. Cancer Sci 95:866-871.
46. Thompson, L. H. and D. Schild. 2002. Recombinational DNA repair and human disease. Mutat Res 509:49-78.
47. Jasin, M. 2002. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 21:8981-8993.
48. Powell, S. N., H. Willers and F. Xia. 2002. BRCA2 keeps Rad51 in line. High-fidelity homologous recombination prevents breast and ovarian cancer? Mol Cell 10:1262-1263.
49. Moynahan, M. E., T. X. Cui and M. Jasin. 2001. Homology-directed DNA repair, mitomycin-C resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res 61:4842-4850.
50. Wang, Y., D. Cortez, P. Yazdi, N. Neff, S. J. Elledge and J. Qin. 2000. BASC, a super complex of BRCA1 -associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14:927-939.
51. Celeste, A., O. Fernandez-Capetillo, M. J. Kruhlak, D. R. Pilch, D. W. Staudt, A. Lee, R. F. Bonner, W. M. Bonner and A. Nussenzweig. 2002. Genomic instability in mice lacking histone H2AX. Science 296:922-927.
52. Kastan M. B. and J. Bartek. 2004. Cellcycle checkpoints and cancer. Nature 432:316-323.
53. Starita, L. M. and J. D. Parvin. 2003. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Curr Opin Cell Biol 15:345-350.
54. Ting, N. S. and W. H. Lee. 2004. The DNA double-strand break response pathway: becoming more BRCAish than ever. DNA Repair 3:935-944.
55. Digweed, M. 2003. Response to environmental carcinogens in DNA-repair-deficient disorders. Toxicology 193:111-124.
56. Surralles, J., S. P. Jackson, M. Jasin, M. B. Kastan, S. C. West and H. Joenje. 2004. Molecular cross-talk among chromosome fragility syndromes. Genes Dev 18:1359-1370.
57. Folias, A., M. Matkovic, D. Bruun, S. Reid, J. Hejna, M. Grompe, A. D. Andrea and R. Moses. 2002. BRCA1 interacts directly with the fanconi anemia protein FANCA. Hum Mol Genet 11:2591-2597.
58. Evans, E. and E. Alani. 2000. Roles for mismatch repair factors in regulating genetic recombination. Mol Cell Biol 20:7839-7844.
59. Schofield, M. J. and P. Hsieh. 2003. DNA mismatch repair: molecular mechanisms and biological function. Annu Rev Microbiol 57:579-608.
60. Surtees, J. A., J. L. Argueso and E. Alani. 2004. Mismatch repair proteins: key regulators of genetic recombination. Cytogenet Genome Res 107:146-159.
61. Sugawara, N., F. Paques, M. Colaiacovo and J. E. Haber. 1997. Role of Saccharomyces cerevisiae Msh2 and Msh3 repair proteins in double-strand break-induced recombination. Proc Natl Acad Sci USA 94:9214-9219.
62. Subramanian, D. and J. D. Griffith. 2002. Interactions between p53, hMSH2hMSH6 and HMG I(Y) on Holliday junctions and bulged bases. Nucleic Acids Res 30:2427-2434.
63. Albrechtsen, N., I. Dornreiter, F. Grosse, E. Kim, L. Wiesmüller and W. Deppert. 1999. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene 18:7706-7717.
64. Dudenhöffer, C., G. Rohaly, K. Will, W Deppert and L. Wiesmüller. 1998. Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol Cell Biol 18:5332-5342.
65. Akyüz, N., G. S. Boehden, S. Süsse, A. Rimek, U. Preuss, K. H. Scheidtmann and L. Wiesmüller. 2002. DNA substrate dependence of p53 -mediated regulation of double-strand break repair. Mol Cell Biol 22:6306-6317.
66. Bertrand, P., Y. Saintigny, B. S. Lopez. 2004. p53's double life: transactivationindependent repression of homologous recombination. Trends Genet 20:235-243.
67. Romanova, L. Y., H. Willers, M. V Blagosklonny and S. N. Powell. 2004. The interaction of p53 with replication protein A mediates suppression of homologous recombination. Oncogene 23:9025-9033.
68. Zink, D., C. Mayr, C. Janz and L. Wiesmüller. 2002. Association of p53 and MSH2 with recombinative repair complexes during S-phase. Oncogene 21:4788-4800.
69. Bachrati, C. Z. and I. D. Hickson. 2003. RecQ helicases: suppressors of tumorigenesis and premature aging. Biochem J 374:577-606.
70. Monnat, R. J. Jr. and Y. Saintigny. 2004. Werner syndrome protein-unwinding function to explain disease. Sci Aging Knowledge Environ 2004:re3.
71. Karow, J. K., A. Constantinou, J. L. Li, S. C. West and I. D. Hickson. 2000. The Bloom's syndrome gene product promotes branch migration of Holliday junctions. Proc Natl Acad Sci USA 97:6504-6508.
72. Wu, L. and I. D. Hickson. 2003. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 426:870-874.
73. Pedrazzi, G., C. Z. Bachrati, N. Selak, I. Studer, M. Petkovic, I. D. Hickson, J. Jiricny and I. Stagljar. 2003. The Bloom's syndrome helicase interacts directly with the human DNA mismatch repair protein hMSH6. Biol Chem 384:1155-1164.
74. Goodarzi, A. A., W. D. Block and S. P. Lees-Miller S. P. 2003. The roles of ATM and ATR in DNA damage-induced cell cycle control. Prog Cell Cycle Res 5:393-411.
75. Bartek, J. and J. Lukas. 2003. Damage alert. Nature 421:486-488.
76. Bakkenist, C. J. and M. B. Kastan. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimmer dissociation. Nature 421:499-506.
77. Kurz, E. U., S. P. and Lees-Miller. 2004. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair 3:889-900.
78. Morrison, C., E. Sonoda, N. Takao, A. Shinohara, K. I. Yamamoto and S. Takeda. 2000. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J 19:463-471.
79. Golding, S. E., E. Rosenberg, A. Khalil, A. McEwen, M. Holmes, S. Neill, L. F. Povirk and K. Valerie. 2004. Double strand break repair by homologous recombination is regulated by cell cycleindependent signaling via ATM in human glioma cells. J Biol Chem 279:15402-15410.
80. Pommier, Y. 2004. Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints. Curr Med Chem Anticancer Ag 4:429-434.
81. Radford, I. R. 2002. Model for the initiation of ionizing radiation-induced apoptosis in lymphoid cells by complex DNA double-strand breaks. Int J Radiat Biol 78: 467-474.
82. Soe, K. and F. Grosse. 2003. p53 stimulates human topoisomerase I activity by modulating its DNA binding. Nucleic Acids Res 31:6585-6592.
83. Malanga, M. and Althaus, F. R. 2004. Poly(ADP-ribose) reactivates stalled DNA topoisomerase I and Induces DNA strand break resealing. J Biol Chem 279:5244-5248.
84. Laine, J. P., P. L. Opresko, F. E. Indig, J. A. Harrigan, C. von Kobbe and V. A. Bohr. 2003. Werner protein stimulates topoisomerase I DNA relaxation activity. Cancer Res. 63:7136-7146.
85. Lengauer, C., K. W. Kinzler and B. Vogelstein. 1998. Genetic instabilities in human cancers. Nature 396:643-649
86. Liehr, J. G. 2001. Genotoxicty of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 7:273-281.
87. Bradbury, P. A. and M. R. Middleton. 2004. DNA repair pathways in drug resistance in melanoma. Anticancer Drugs 15:421-426.